Todd Bazemore's Net Worth
$1.24 Million
Who is Todd Bazemore?
Todd Bazemore has an estimated net worth of $1.24 Million. This is based on reported shares across multiple companies, which include Pulmatrix, Inc., Kala Pharmaceuticals, Inc., and DYAX CORP.
SEC CIK
Todd Bazemore's CIK is 0001605767
Past Insider Trading and Trends
2020 was Todd Bazemore's most active year for acquiring shares with 7 total transactions. Todd Bazemore's most active month to acquire stocks was the month of December. 2023 was Todd Bazemore's most active year for disposing of shares, totalling 9 transactions. Todd Bazemore's most active month to dispose stocks was the month of April. 2017 saw Todd Bazemore paying a total of $3,371,200.00 for 172,000 shares, this is the most they've acquired in one year. In 2015 Todd Bazemore cashed out on 99,750 shares for a total of $1,015,623.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Pulmatrix, Inc. (PULM) Snapshot price: $1.75
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KALA BIO, Inc. (KALA) Snapshot price: $7.27
SEE REMARKS
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.31% | -4.65K |
$4.75 | -$22,101.75 | 83.04K |
Jun 26
| |||
Form 4
| -2.33% | -2.09K |
$6.09 | -$12,746.37 | 87.69K |
May 31
| |||
Form 4
|
∞
| 5.09K |
$6.74 | -$9,469.70 | 13.32K |
Jan 4
| |||
Form 4
| +135.30% | 48.7K |
—
|
—
| 84.69K |
Jun 22
| |||
Form 4
| +142.62% | 21.16K |
—
|
—
| 35.99K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
| +607.44% | 12.74K |
$28.54 | -$1,769.48 | 14.84K |
Scheduled
|
Jan 4
| ||
Form 4
| -9.26% | -214.00 |
$6.51 | -$1,393.14 | 2.1K |
Scheduled
|
Oct 26
| ||
Form 4
| -2.61% | -3.09K |
$0.37 | -$1,144.04 | 115.5K |
Scheduled
|
Jun 27
| ||
Form 4
| -2.83% | -3.45K |
$1.30 | -$4,490.20 | 118.59K |
Scheduled
|
Jan 3 - Jan 4
| ||
Form 4
| -9.32% | -12.54K |
$1.80 | -$22,579.20 | 122.05K |
Scheduled
|
Oct 26
| ||
Form 4
| -11.10% | -2.91K |
$5.77 | -$16,796.47 | 23.33K |
Scheduled
|
Jun 28
| ||
Form 4
| +25.00% | 27.5K |
—
|
—
| 137.5K |
Jan 4
| |||
Form 4
| +279.46% | 81.04K |
$7.88 | $330.78 | 110.04K |
Jun 5 - Oct 26
| |||
Form 4
| +190.00% | 19K |
—
|
—
| 29K |
Jun 25
| |||
Form 4
|
∞
| 10K |
$5.75 | $57,500.00 | 10K |
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DYAX CORP No price found
EVP & Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -13.75K |
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
∞
| 13.75K |
$6.80 | $93,500.00 | 13.75K |
Aug 18
| |||
Form 4
|
—
|
0
|
$15.21 | -$723,223.00 |
0
|
Aug 4 - Aug 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||